Tantalus Systems
Trending >

Canopy Growth Corp. is a first-mover on the international market, GMP says

TerrAscend

AYR Strategies A partnership that will bring Canada’s Canopy Growth Corp. (Canopy Growth Corp. Stock Quote, Chart, News: TSX:WEED) into the Danish market is a positive development, GMP Securities analyst Martin Landry says.

This morning, Canopy announced it had reached a partnership with Danish Cannabis ApS to form a new firm called Spectrum Denmark ApS. Canopy said despite impending legalization in that country, the market has to date been served by expensive compinds supplied by a single pharmacy.

“International market opportunities are emerging quickly and Canopy has the experience and expertise to turn these opportunities into greater shareholder value,” said Canopy CEO Bruce Linton. “Our approach is clear: establishing the brands, infrastructure and people in a systematic manner to ensure success across numerous federally legal geographies. With Spectrum in particular, our goal is to redefine what a global medical cannabis producer looks like in the minds of doctors, regulators and patients.”

Landry says this Denmark Joint Venture expands Canopy’s presence in Europe and underpins the trend of growing its international opportunities.

“The medical cannabis trial in Denmark is initially expected to be relatively small (government anticipates participation of ~500 patients at the outset, growing to 1,500 by 2021), however, we expect the program could expand faster than government projections,” the analyst says. “Hence, Spectrum Denmark should represent an interesting opportunity for Canopy given a firstmover advantage, and lack of significant competitors currently. Spectrum Denmark expands Canopy’s global exposure, adding to the list which already includes Germany, Brazil, Chile, Australia, and Spain. In our view, this underpins the trend of growing international opportunities for Canadian LPs, highlighting the potential for global medical cannabis to evolve into a ~$40–50b market in the future.”

In a research update to clients today, Landry maintained his “Buy” rating and one-year price target of $11.00 on Canopy Growth Corp, implying a return of four per cent at the time of publication.

  •  
  • 2
  •  

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cantech Alerts.

Timely picks from Canada's best analysts. 

F                                                                      
close-link